Global Urinalysis Market : Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2021

The report covers detailed analysis and forecast for the urinalysis market on a global and regional level from 2015 to 2021. The study offers historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD billion).

The report covers detailed analysis and forecast for the urinalysis market on a global and regional level from 2015 to 2021. The study offers historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD billion).  The study includes a comprehensive view of the market with the review of market drivers, restraint, and opportunities. It also offers the level of impact of drivers and restraints on the Urinalysis market between 2015 and 2021.

The study included a detailed competitive scenario and product portfolio of key vendors. The report evaluates Porter’s Five Forces model to analyze the different factors affecting the growth of the urinalysis market. Moreover, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by product, application, and region.

The report includes detailed segmentation of urinalysis market based on product, application, and region. Consumables are the key product segment in the urinalysis market. On the basis of application segment, the market can be classified into Kidney diseases, hypertension, urinary tract infection, diabetes, liver diseases and other applications. Major regional segment analyzed in this report include Asia Pacific, North America, Europe, Latin America and the Middle East & Africa with its further bifurcation into major countries including China, Japan, India, U.S. Germany, France, UK, and Brazil.

The report provides detailed competitive outlook including market share and company profiles of the key players operating in the global market. Some of the key participants in the report include Mindray, Roche Diagnostics, Siemens Healthcare, Sysmex, ARKRAY Inc., Alere Inc., ACON Laboratories, Inc., Bio-Rad, Labomed, Inc.Teco Diagnostics and Urit Medical., among others.

This report segments the global urinalysis market as follows:

Global Urinalysis Market: Product Segment Analysis

  • Consumables
  • Instruments

Global Urinalysis Market: Application Segment Analysis

  • Kidney Diseases
  • Hypertension
  • Urinary Tract Infection
  • Diabetes
  • Liver Diseases
  • Others

Global Urinalysis Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa
Table of Contents
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Urinalysis market, 2015 – 2021 (USD Billion)
    • 2.2. Global Urinalysis market : Snapshot
  • Chapter 3. Urinalysis – Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Urinalysis market drivers: Impact analysis
      • 3.2.2. Increasing Aged Population Globally
      • 3.2.3. Increasing Incidences of Target Diseases
    • 3.3. Market restraints
      • 3.3.1. Lack of Healthcare Infrastructure
      • 3.3.2. Strict Government Regulations
    • 3.4. Opportunities
      • 3.4.1. Unmet Clinical Needs in Under Developed Countries
    • 3.5. Porter’s five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by application segment
      • 3.6.3. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Urinalysis Market – Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Urinalysis market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Product and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Product Portfolio
    • 4.5. Patent Analysis (2011-2016)
      • 4.5.1. Patent Trend
      • 4.5.2. Patent Share by company
      • 4.5.3. By Region
  • Chapter 5. Global Urinalysis Market – Product Segment Analysis
    • 5.1. Global Urinalysis market: Product overview
      • 5.1.1. Global Urinalysis market revenue share, by product, 2015 and 2021
    • 5.2. Consumables
      • 5.2.1. Global Consumables market, 2015 – 2021(USD Billion)
    • 5.3. Instruments
      • 5.3.1. Global Instruments market, 2015 – 2021(USD Billion)
  • Chapter 6. Global Urinalysis Market – Application Segment Analysis
    • 6.1. Global Urinalysis market: Application overview
      • 6.1.1. Global Urinalysis market revenue share, by Application, 2015 and 2020
    • 6.2. Kidney Diseases
      • 6.2.1. Global Urinalysis market for Kidney Diseases, 2015 – 2021 (USD Billion)
    • 6.3. Hypertension
      • 6.3.1. Global Urinalysis market for Hypertension, 2015 – 2021(USD Billion)
    • 6.4. Urinary Tract Infection
      • 6.4.1. Global Urinalysis market for Urinary Tract Infection, 2015 – 2021 (USD Billion)
    • 6.5. Diabetes
      • 6.5.1. Global Urinalysis market for Diabetes, 2015 - 2021(USD Billion)
    • 6.6. Liver Diseases
      • 6.6.1. Global Urinalysis market for Liver Diseases, 2015 - 2021(USD Billion)
    • 6.7. Others
      • 6.7.1. Global Urinalysis market for other Application , 2015 – 2021 (USD Billion)
  • Chapter 7. Global Urinalysis Market – Regional Segment Analysis
    • 7.1. Global Urinalysis market: Regional overview
      • 7.1.1. Global Urinalysis market revenue share, by region, 2015 and 2021
    • 7.2. North America
      • 7.2.1. North America Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
      • 7.2.2. North America Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
        • 7.2.3.2. U.S. Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
      • 7.3.2. Europe Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
      • 7.3.3. Germany
        • 7.3.3.1. Germany Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
        • 7.3.3.2. Germany Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
      • 7.3.4. France
        • 7.3.4.1. France Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
        • 7.3.4.2. France Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
      • 7.3.5. UK
        • 7.3.5.1. UK Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
        • 7.3.5.2. UK Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Urinalysis market revenue, by product, 2015 – 2021, (USD Billion)
      • 7.4.2. Asia Pacific Urinalysis market revenue, by Application, 2015 – 2021, (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
        • 7.4.3.2. China Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
        • 7.4.4.2. Japan Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
        • 7.4.5.2. India Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
      • 7.5.2. Latin America Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Urinalysis market revenue, by product, 2015 – 2021(USD Billion)
        • 7.5.3.2. Brazil Urinalysis market revenue, by Application, 2015 – 2021 (USD Billion)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa Urinalysis market revenue, by product, 2015 – 2021 (USD Billion)
      • 7.6.2. Middle East and Africa Urinalysis market revenue, by Application, 2015 – 2021(USD Billion)
  • Chapter 8. Company Profile
    • 8.1. Mindray
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Roche Diagnostics
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Siemens Healthcare
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Sysmex
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. ARKRAY Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Alere Inc.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. ACON Laboratories, Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Bio-Rad
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Labomed, Inc.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Teco Diagnostics
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments
    • 8.11. Urit Medical
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product portfolio
      • 8.11.4. Business strategy
      • 8.11.5. Recent developments


Your Name (required)

Your Email (required)

Telephone Number (required)

Name of company (required)

Country Name (required)

How can we help you?

Prove You are Human (required)


Enter Capcha Image Properly